✦ LIBER ✦

Balancing the benefits of statins versus a new risk—diabetes

✍ Scribed by Christopher P Cannon

Book ID: 117306241
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 138 KB
Volume: 375
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)60234-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Balancing the cardiometabolic benefits a

Balancing the cardiometabolic benefits and risks of statins

✍ Gerald F Watts; Esther M Ooi 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 107 KB

Risk of New-Onset Diabetes Mellitus Vers

Risk of New-Onset Diabetes Mellitus Versus Reduction in Cardiovascular Events With Statin Therapy

✍ Wang, Kang-Ling; Liu, Chia-Jen; Chao, Tze-Fan; Chen, Su-Jung; Wu, Cheng-Hsueh; H 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 780 KB

Balancing the benefits and risks of new

Balancing the benefits and risks of new drugs for MS

✍ The Lancet Neurology 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 29 KB

The Balance of Risks and Benefits of Dru

The Balance of Risks and Benefits of Drug-Eluting Versus Bare-Metal Stents

✍ Matthias Pfisterer; Hans Peter Brunner-La Rocca; Christoph Kaiser 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Statins and Risk of New-Onset Diabetes M

Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?

✍ Navarese, Eliano Pio; Szczesniak, Anna; Kolodziejczak, Michalina; Gorny, Bartosz 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 435 KB

Metformin revisited: A critical review o

Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes

✍ Scheen, A.J.; Paquot, N. 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 620 KB